These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16403588)

  • 21. [Pathogenetic substantiation of the liquid technique for eradication of Helicobacter pylori infection in the stomach].
    Morozov IA
    Eksp Klin Gastroenterol; 2006; (1):89-93. PubMed ID: 16866253
    [No Abstract]   [Full Text] [Related]  

  • 22. Gastroretentive delivery systems: a mini review.
    Talukder R; Fassihi R
    Drug Dev Ind Pharm; 2004; 30(10):1019-28. PubMed ID: 15595568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of four different primer sets for detection of Helicobacter pylori in gastric biopsies and oral samples by using real-time PCR].
    Diouf A; Martinez-Gomis J; Miquel M; Quesada M; Lario S; Sixou M
    Pathol Biol (Paris); 2009 Feb; 57(1):30-5. PubMed ID: 18842355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of Postprandial Intragastric Pressures on Drug Release from Gastroretentive Dosage Forms.
    Schneider F; Hoppe M; Koziolek M; Weitschies W
    AAPS PharmSciTech; 2018 Oct; 19(7):2843-2850. PubMed ID: 29845498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of drug delivery to improve antibiotic targeting to the stomach.
    Adebisi AO; Conway BR
    Ther Deliv; 2015; 6(6):741-62. PubMed ID: 26149788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Helicobacter pylori and gastric cancer].
    Ramírez Ramos A; Sánchez Sánchez R
    Rev Gastroenterol Peru; 2008; 28(3):258-66. PubMed ID: 18958142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sinking-magnetic microparticles prepared by the electrospray method for enhanced gastric antimicrobial delivery.
    Hao S; Wang Y; Wang B
    Mol Pharm; 2014 May; 11(5):1640-50. PubMed ID: 24679346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the intragastric location of extended release tablets on food interactions.
    Weitschies W; Wedemeyer RS; Kosch O; Fach K; Nagel S; Söderlind E; Trahms L; Abrahamsson B; Mönnikes H
    J Control Release; 2005 Nov; 108(2-3):375-85. PubMed ID: 16213057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intensification of Helicobacter pylori colonization and serological markers of Helicobacter pylori infection and cytotoxicity in blood].
    Bak-Romaniszyn L; Kałuzyński A; Chmiela M; Rudnicka W; Kulig A; Płaneta-Małecka I
    Pol Merkur Lekarski; 2009 May; 26(155):407-11. PubMed ID: 19606685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Optimization, and Evaluation of a Novel Metronidazole-Loaded Gastro-Retentive pH-Sensitive Hydrogel.
    El-Mahrouk GM; Aboul-Einien MH; Makhlouf AI
    AAPS PharmSciTech; 2016 Dec; 17(6):1285-1297. PubMed ID: 26689404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expandable gastroretentive dosage forms.
    Klausner EA; Lavy E; Friedman M; Hoffman A
    J Control Release; 2003 Jun; 90(2):143-62. PubMed ID: 12810298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Helicobacter pylori eradication on methylation status of E-cadherin gene in noncancerous stomach.
    Leung WK; Man EP; Yu J; Go MY; To KF; Yamaoka Y; Cheng VY; Ng EK; Sung JJ
    Clin Cancer Res; 2006 May; 12(10):3216-21. PubMed ID: 16707623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.
    Ogura K; Hirata Y; Yanai A; Shibata W; Ohmae T; Mitsuno Y; Maeda S; Watabe H; Yamaji Y; Okamoto M; Yoshida H; Kawabe T; Omata M
    J Clin Gastroenterol; 2008 Mar; 42(3):279-83. PubMed ID: 18223496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan-based gastroretentive floating drug delivery technology: an updated review.
    Pahwa R; Saini N; Kumar V; Kohli K
    Expert Opin Drug Deliv; 2012 May; 9(5):525-39. PubMed ID: 22444200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?
    de Vries AC; Kuipers EJ; Rauws EA
    Am J Gastroenterol; 2009 Jun; 104(6):1342-5. PubMed ID: 19491846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Floating in situ gelling system of acetohydroxamic acid for clearance of H. pylori.
    Rajinikanth PS; Mishra B
    Drug Dev Ind Pharm; 2008 Jun; 34(6):577-87. PubMed ID: 18568907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship between the presence of Helicobacter pylori in the oral cavity and gastric in the stomach.
    Loster BW; Majewski SW; Cześnikiewicz-Guzik M; Bielanski W; Pierzchalski P; Konturek SJ
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():91-100. PubMed ID: 17033108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Helicobacter pylori resistance rate to clarithromycin in Turkey.
    Onder G; Aydin A; Akarca U; Tekin F; Ozutemiz O; Ilter T
    J Clin Gastroenterol; 2007 Sep; 41(8):747-50. PubMed ID: 17700422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Comparative evaluation of the gastric transit of floating and non-floating matrix dosage forms].
    Timmermans J
    Bull Mem Acad R Med Belg; 1990; 145(8-9):365-75. PubMed ID: 2099235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.